Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

May salivary alpha-amylase level be a useful tool for assessment of the severity of schizophrenia and evaluation of therapy? A case report.

Ieda M, Miyaoka T, Kawano K, Wake R, Inagaki T, Horiguchi J.

Case Rep Psychiatry. 2012;2012:747104. doi: 10.1155/2012/747104. Epub 2012 Sep 30.

2.

High salivary alpha-amylase levels in patients with schizophrenia: A pilot study.

Inagaki T, Miyaoka T, Okazaki S, Yasuda H, Kawamukai T, Utani E, Wake R, Hayashida M, Horiguchi J, Tsuji S.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 May 30;34(4):688-91. doi: 10.1016/j.pnpbp.2010.03.024. Epub 2010 Mar 27.

PMID:
20347911
3.

Evaluation of autonomic nervous system by salivary alpha-amylase level and heart rate variability in patients with schizophrenia.

Ieda M, Miyaoka T, Wake R, Liaury K, Tsuchie K, Fukushima M, Araki T, Ezoe S, Inagaki T, Horiguchi J.

Eur Arch Psychiatry Clin Neurosci. 2014 Feb;264(1):83-7. doi: 10.1007/s00406-013-0411-6. Epub 2013 May 5.

PMID:
23645102
4.

[Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].

Lévy-Rueff M, Jurgens A, Lôo H, Olié JP, Amado I.

Encephale. 2008 Oct;34(5):526-33. doi: 10.1016/j.encep.2007.08.008. Epub 2008 Jan 11. French.

PMID:
19068343
5.

[Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].

Askenazy F, Dor E, Benoit M, Dupuis G, Serret S, Myquel M, Seddiki Y.

Encephale. 2010 Feb;36(1):46-53. doi: 10.1016/j.encep.2009.01.006. Epub 2009 May 12. French.

PMID:
20159196
6.

Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia.

Suzuki K, Awata S, Takano T, Ebina Y, Iwasaki H, Matsuoka H.

Psychiatry Clin Neurosci. 2005 Aug;59(4):481-9.

7.
8.

Salivary alpha-amylase and cortisol responsiveness following electrical stimulation stress in major depressive disorder patients.

Tanaka Y, Ishitobi Y, Maruyama Y, Kawano A, Ando T, Okamoto S, Kanehisa M, Higuma H, Ninomiya T, Tsuru J, Hanada H, Kodama K, Isogawa K, Akiyoshi J.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Mar 30;36(2):220-4. doi: 10.1016/j.pnpbp.2011.10.005. Epub 2011 Oct 29.

PMID:
22063648
9.

Brain-derived neurotrophic factor and electroconvulsive therapy in a schizophrenic patient with treatment-resistant paranoid-hallucinatory symptoms.

Martinotti G, Ricci V, Di Nicola M, Caltagirone C, Bria P, Angelucci F.

J ECT. 2011 Mar;27(1):e44-6. doi: 10.1097/YCT.0b013e318205e1c0. Review.

PMID:
21206369
10.

[A rare and not very studied disorder: childhood-onset schizophrenia. A case report].

Bailly D, de Chouly de Lenclave MB.

Encephale. 2004 Nov-Dec;30(6):540-7. French.

PMID:
15738856
11.

Salivary α-amylase and cortisol responsiveness following electrical stimulation stress in panic disorder patients.

Tanaka Y, Ishitobi Y, Maruyama Y, Kawano A, Ando T, Imanaga J, Okamoto S, Kanehisa M, Higuma H, Ninomiya T, Tsuru J, Hanada H, Isogawa K, Akiyoshi J.

Neurosci Res. 2012 May;73(1):80-4. doi: 10.1016/j.neures.2012.01.006. Epub 2012 Feb 27.

PMID:
22391145
12.

[Psychiatric manifestations of vitamin B12 deficiency: a case report].

Durand C, Mary S, Brazo P, Dollfus S.

Encephale. 2003 Nov-Dec;29(6):560-5. French.

PMID:
15029091
13.
14.

[Catatonia: resurgence of a concept. A review of the international literature].

Pommepuy N, Januel D.

Encephale. 2002 Nov-Dec;28(6 Pt 1):481-92. Review. French.

PMID:
12506260
15.

Does catatonic schizophrenia improve faster with electroconvulsive therapy than other subtypes of schizophrenia?

Thirthalli J, Phutane VH, Muralidharan K, Kumar CN, Munishwar B, Baspure P, Gangadhar BN.

World J Biol Psychiatry. 2009;10(4 Pt 3):772-7. doi: 10.1080/15622970902718782.

PMID:
19225955
16.

Moderate clinical improvement with maintenance ECT in a 17-year-old boy with intractable catatonic schizophrenia.

Consoli A, Boulicot V, Cornic F, Fossati P, Barbeau M, Cohen D.

Eur Child Adolesc Psychiatry. 2009 Apr;18(4):250-4. doi: 10.1007/s00787-008-0724-6. Epub 2009 Jan 20.

PMID:
19156356
17.
19.

Determinants of salivary evening α-amylase in a large sample free of psychopathology.

Veen G, Giltay EJ, Vreeburg SA, Licht CM, Cobbaert CM, Zitman FG, Penninx BW.

Int J Psychophysiol. 2012 Apr;84(1):33-8. doi: 10.1016/j.ijpsycho.2012.01.005. Epub 2012 Jan 23.

PMID:
22273538
20.

Efficacy of electroconvulsive therapy in treatment-resistant schizophrenia: a prospective open trial.

Tang WK, Ungvari GS.

Prog Neuropsychopharmacol Biol Psychiatry. 2003 May;27(3):373-9.

PMID:
12691772
Items per page

Supplemental Content

Write to the Help Desk